RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Clinical trial NCT00358215 · COMPLETED

Trial details

NCT number: NCT00358215
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure Anemia Cardiovascular Disease Ventricular Dysfunction Congestive Heart Failure

Start date: 2006-06-01
Primary completion: 2012-10-11
Enrollment: 2278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.